Resultados de procura - Thomas G. Graeber
- Mostrando 1 - 20 Resultados de 85
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Myc-driven murine prostate cancer shares molecular features with human prostate tumors por Katharine Ellwood‐Yen, Thomas G. Graeber, John Wongvipat, M. Luisa Iruela‐Arispe, Jianfeng Zhang, Robert J. Matusik, George Thomas, Charles L. Sawyers
Publicado 2003Artigo -
9
Adenovirus E4ORF1-Induced MYC Activation Promotes Host Cell Anabolic Glucose Metabolism and Virus Replication por Minh Thai, Nicholas A. Graham, Daniel Braas, Michael Nehil, Evangelia Komisopoulou, Siavash K. Kurdistani, Frank McCormick, Thomas G. Graeber, Heather R. Christofk
Publicado 2014Artigo -
10
-
11
-
12
-
13
-
14
Global Phosphoproteomics Reveals Crosstalk Between Bcr-Abl and Negative Feedback Mechanisms Controlling Src Signaling por Liudmilla Rubbi, Bjoern Titz, Lauren Brown, Erica Galvan, Evangelia Komisopoulou, Sharon S. Chen, Tracey Low, Martik Tahmasian, Brian J. Skaggs, Markus Müschen, Matteo Pellegrini, Thomas G. Graeber
Publicado 2011Artigo -
15
Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets por Justin M. Drake, Nicholas Graham, John K. Lee, Tanya Stoyanova, Claire Faltermeier, Sudha Sud, Bjoern Titz, Jiaoti Huang, Kenneth J. Pienta, Thomas G. Graeber, Owen N. Witte
Publicado 2013Artigo -
16
Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma por Mohammad Atefi, Earl Avramis, Amanda Lassen, Deborah J. Wong, Lídia Robert, David Foulad, Michael Cerniglia, Bjoern Titz, Thinle Chodon, Thomas G. Graeber, Begonya Comin-Anduix, Antoni Ribas
Publicado 2014Artigo -
17
Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth por David J. Mulholland, Linh M. Tran, Yunfeng Li, Houjian Cai, Ashkan Morim, Shunyou Wang, Seema B. Plaisier, Isla P. Garraway, Jiaoti Huang, Thomas G. Graeber, Hong Wu
Publicado 2011Artigo -
18
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in <i>BRAF</i> <sup> <i>V600E</i> </sup> melanoma por Siwen Hu‐Lieskovan, Stephen Mok, Blanca Homet Moreno, Jennifer Tsoi, Lídia Robert, Lucas Goedert, Elaine M. Pinheiro, Richard C. Koya, Thomas G. Graeber, Begoña Comı́n-Anduix, Antoni Ribas
Publicado 2015Artigo -
19
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma por Mohammad Atefi, Bjoern Titz, Earl Avramis, Charles Ng, Deborah J. Wong, Amanda Lassen, Michael Cerniglia, Helena Escuin-Ordinas, David Foulad, Begonya Comin-Anduix, Thomas G. Graeber, Antoni Ribas
Publicado 2015Artigo -
20
BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy por Richard C. Koya, Stephen Mok, Nicholas Otte, Kevin J. Blacketor, Begonya Comin-Anduix, Paul C. Tumeh, Aspram Minasyan, Nicholas A. Graham, Thomas G. Graeber, Thinle Chodon, Antoni Ribas
Publicado 2012Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Cancer research
Genetics
Gene
Cell biology
Biochemistry
Medicine
Cancer
Immunology
Internal medicine
Signal transduction
Computational biology
Melanoma
Chemistry
Cell
Gene expression
Immune system
Kinase
Receptor
Bioinformatics
Transcription factor
Prostate cancer
Immunotherapy
Mutation
PI3K/AKT/mTOR pathway
Pathology
Phosphorylation
Tyrosine kinase
Metabolism
T cell